BiotechTube
Single Cell Discoveries

Single Cell Discoveries

Utrecht, Netherlands· Est.
scdiscoveries.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10.5M

Overview

Single Cell Discoveries is an established, privately-held transcriptomics CRO based in Utrecht, Netherlands, that has been operating since 2012. It offers a comprehensive suite of sequencing and data analysis services, leveraging deep expertise across multiple technology platforms, including 10x Genomics, Visium HD, and proprietary assays like SORT-seq and DRUG-seq. The company's core value proposition is its scientist-led, collaborative approach, ensuring optimal experimental design and rapid, reliable data delivery for clients in drug development, oncology, immunology, and neuroscience. It is a revenue-generating services business trusted by academic and biopharmaceutical clients.

OncologyImmunologyNeuroscienceDevelopmental Biology

Technology Platform

Technology-agnostic transcriptomics service platform integrating commercial (e.g., 10x Genomics, Visium HD) and proprietary assays (SORT-seq, DRUG-seq) for end-to-end bulk, single-cell, and spatial RNA sequencing with integrated data analysis.

Funding History

2
Total raised:$10.5M
Series A$8M
Seed$2.5M

Opportunities

The growing adoption of single-cell and spatial transcriptomics in biopharma R&D and academia presents a large and expanding market.
SCD's technology-agnostic, scientist-led model is well-suited to capture clients seeking expert guidance and reliable data for critical decision-making, especially in complex fields like immuno-oncology and neuroscience.
Further opportunity lies in developing deeper, programmatic partnerships with drug developers and expanding proprietary assay offerings.

Risk Factors

Key risks include dependence on third-party technology platforms, intense competition from other CROs and core labs, potential cyclicality in client research funding, and the challenge of retaining specialized scientific talent in a competitive job market.
Failure to continuously adopt or develop best-in-class technologies could erode its value proposition.

Competitive Landscape

SCD competes in the specialized transcriptomics CRO space against other focused service providers (e.g., GenomeScan, Azenta), the in-house core facilities of major academic institutions, and the service arms of large sequencing companies. Its differentiation hinges on deep technical expertise, a collaborative scientific partnership model, rapid turnaround, and a broad, validated portfolio of both commercial and proprietary technologies.

More companies in Diagnostics & Precision Medicine →More companies in Netherlands →